🔎 Trials Near Me

Почетна › Рак плућа › Њујорк › Rochester

Kliničke studije za Рак плућа u gradu Rochester, NY

15 studija za Рак плућа traži učesnike na lokacijama u gradu Rochester i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Тражи се учесникФаза 2/3
  • Local Institution - 0128, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07063745

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Тражи се учесникФаза 2/3
  • Rochester General Hospital Infectious Disease, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07100080

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Тражи се учесникФаза 3
  • Rochester General Hospital, Rochester
  • University of Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Тражи се учесникФаза 3
  • University of Rochester, Rochester
  • Wilmot Cancer Institute at Webster, Webster · 10 ми удаљено
Узраст 70 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06096844

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Тражи се учесникФаза 1
  • University of Rochester - Wilmot Cancer Institute, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06582017

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • University of Rochester, Rochester
18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2/3
  • University of Rochester, Rochester
  • Wilmot Cancer Institute at Webster, Webster · 10 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Wilmot Cancer Institute Radiation Oncology at Greece, Rochester
  • Highland Hospital, Rochester
  • University of Rochester, Rochester
  • и још 2
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT05624996

Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy

Тражи се учесникОпсервациона студија
  • University of Rochester Medical Center, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 30. 7. 2026. · NCT06410300

Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

Тражи се учесник
  • James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 20. 7. 2026. · NCT03706027

Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy

Тражи се учесникЗдраве особе су добродошле
  • University of Rochester, Rochester
Узраст 60 и старији · Оба пола · Ажурирано 8. 7. 2026. · NCT06139627

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • University of Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT05642572

Increasing Lung Cancer Screening Uptake Among Emergency Department Patients

Тражи се учесникЗдраве особе су добродошле
  • University of Rochester, Rochester
Узраст од 50 до 80 · Оба пола · Ажурирано 4. 5. 2026. · NCT07287085

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Тражи се учесникОпсервациона студија
  • Wilmot Cancer Institute Radiation Oncology at Greece, Rochester
  • Highland Hospital, Rochester
  • Pluta Cancer Center, Rochester
  • и још 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 1. 2026. · NCT06073431

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Тражи се учесникОпсервациона студија
  • University of Rochester Medical Center, Rochester
Узраст од 29 до 85 · Оба пола · Ажурирано 13. 11. 2024. · NCT06426628

Studije za Рак плућа u drugim gradovima

Ostale studije u gradu Rochester

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.